Literature DB >> 21623837

Molecular and functional identification of organic anion transporter isoforms in cultured bovine mammary epithelial cells (BME-UV).

M M Al-Bataineh1, D Van Der Merwe, B D Schultz, R Gehring.   

Abstract

Mammary epithelial cells express a diversity of membrane transporters including members of organic cation and organic anion (OAT) transporter subfamilies. Four mammal OAT isoforms have been identified: OAT-1, OAT-2, OAT-3, and OAT-4. The pharmacological significance of OAT isoforms has been emphasized because of their role in the movement of a wide variety of substrates across epithelial barriers. The present study identified (molecularly and functionally) bovine OAT isoforms in bovine mammary epithelial (BME-UV) cells. mRNA expression levels of all tested transporters in BME-UV cells were less than expression levels of the corresponding transporters in bovine kidney. Directionality in the flux of P-aminohippuric acid and acetylsalicylate, compounds known to interact with OAT-1 and OAT-2, respectively, across BME-UV monolayers was not observed at the concentrations used in this study. Directionality was, however, observed in the flux of estrone sulfate (EsS). Adding probenecid, penicillin G or nonradiolabeled EsS to the apical donor compartment significantly increased the apical-to-basolateral flux of EsS across the BME-UV monolayer. These results suggest that BME-UV cells express an organic anion transport system, making it a potentially useful model to study the role of this transport system in the mammary epithelial barrier.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623837      PMCID: PMC3165114          DOI: 10.1111/j.1365-2885.2011.01309.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  39 in total

1.  Expression cloning and characterization of a novel multispecific organic anion transporter.

Authors:  T Sekine; N Watanabe; M Hosoyamada; Y Kanai; H Endou
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain.

Authors:  H Kusuhara; T Sekine; N Utsunomiya-Tate; M Tsuda; R Kojima; S H Cha; Y Sugiyama; Y Kanai; H Endou
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

Review 3.  Cell culture techniques for the study of drug transport.

Authors:  G Wilson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 4.  The multispecific organic anion transporter family: properties and pharmacological significance.

Authors:  Hiroki Miyazaki; Takashi Sekine; Hitoshi Endou
Journal:  Trends Pharmacol Sci       Date:  2004-12       Impact factor: 14.819

Review 5.  Molecular pharmacology of organic cation transporters in kidney.

Authors:  H Koepsell; V Gorboulev; P Arndt
Journal:  J Membr Biol       Date:  1999-01-15       Impact factor: 1.843

6.  Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1.

Authors:  I Tamai; H Yabuuchi; J Nezu; Y Sai; A Oku; M Shimane; A Tsuji
Journal:  FEBS Lett       Date:  1997-12-08       Impact factor: 4.124

7.  Active transport of nitrofurantoin across the mammary epithelium in vivo.

Authors:  F W Kari; R Weaver; M C Neville
Journal:  J Pharmacol Exp Ther       Date:  1997-02       Impact factor: 4.030

8.  Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine.

Authors:  T Sekine; H Kusuhara; N Utsunomiya-Tate; M Tsuda; Y Sugiyama; Y Kanai; H Endou
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

9.  Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.

Authors:  I Tamai; R Ohashi; J Nezu; H Yabuuchi; A Oku; M Shimane; Y Sai; A Tsuji
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

10.  Identification of multispecific organic anion transporter 2 expressed predominantly in the liver.

Authors:  T Sekine; S H Cha; M Tsuda; N Apiwattanakul; N Nakajima; Y Kanai; H Endou
Journal:  FEBS Lett       Date:  1998-06-12       Impact factor: 4.124

View more
  1 in total

1.  E. coli infection modulates the pharmacokinetics of oral enrofloxacin by targeting P-glycoprotein in small intestine and CYP450 3A in liver and kidney of broilers.

Authors:  Mengjie Guo; Yong Sun; Yu Zhang; Shamsuddin Bughio; Xiaohua Dai; Weilong Ren; Liping Wang
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.